Following temporary changes to the Equine Influenza vaccination requirements earlier this year, we indicated that we would be consulting on changes to the permanent EI vaccination rule prior to the end of 2019.Continue reading
The BHA, in conjunction with the independent, industry represented BHA Veterinary Committee, would like to update industry stakeholders in regard to the potential administration of bisphosphonates to horses under the age of three years and six months in international racing jurisdictions. This is a particular consideration during the sales period.Continue reading
BHA provide an update on Summary of Requirements from 17 September 2019 for Equine Influenza.Continue reading
The BHA would like to make Trainers, veterinary surgeons and other industry participants aware of an international issue regarding injectable omeprazole manufactured by BOVA.Continue reading
The BHA have published updated Drug Detection Times as of 1st June 2019 in light of new published drug detection times.
The document is available in the Downloads section of the Members area.
The British Horseracing Authority (BHA) would like to advise the Responsible Person (i.e. trainers, owners, breeders) and their veterinary surgeons of a new Detection Time for misoprostol and xylazine, and an updated Detection Time for dantrolene. These Detection Times will be effective from 01 June 2019.
The published notice is available at this link
The British Horseracing Authority (BHA) is to consult with the National Trainers Federation (NTF) and other industry stakeholders on permanent changes to racing’s rules to strengthen protection against equine influenza.Continue reading
BHA refine processes in relation to the current equine influenza requirements, to make things work more smoothly and effectively.Continue reading
The BHA have updated Detection Time for omeprazole it being reduced from 72 hours to 48 hours.Continue reading